Vesicular pityriasis rosea: response to erythromycin treatment.
Pityriasis rosea (PR) is a relatively common disease although its aetiology has not yet been identified. It occurs worldwide and there is no racial susceptibility factor. It usually affects teenagers and young adults between 10 and 35 years of age. Typical PR is much easier to diagnose than the rare atypical forms. We report a rare case of vesicular PR in a black woman who had vesicular lesions limited to her palms and soles in addition to regular typical lesions. We devised an efficient oral erythromycin treatment for this patient.
Miranda
S B
SB
Dermatology Department, Clinical Hospital of Federal University/UFES, Vitória, Brazil. sandra.bittencourt@terra.com.br
Lupi
O
O
Lucas
E
E
D000284:Administration, Oral; D000328:Adult; D000900:Anti-Bacterial Agents / Q000008:administration & dosage; D003937:Diagnosis, Differential; D004917:Erythromycin / Q000008:administration & dosage; D005260:Female; D005528:Foot; D006225:Hand; D006801:Humans; D017515:Pityriasis Rosea / Q000175:diagnosis* / Q000473:pathology
D000900:Anti-Bacterial Agents; D004917:Erythromycin